322 filings
Page 2 of 17
8-K
yx30z7yh1jvpd
15 May 23
Eloxx Pharmaceuticals Reports First Quarter 2023 Financial and Operating Results and Provides Business Update
6:01pm
8-K
ll63f0
14 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
k51ut dd0cx
3 Apr 23
Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update
9:27am
8-K
1kks 7alq6
9 Mar 23
Entry into a Material Definitive Agreement
4:12pm
8-K
vi1gwao
1 Dec 22
Eloxx Pharmaceuticals Announces Reverse Stock Split Effective
5:04pm
8-K
umukgp13
14 Nov 22
Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
4:09pm
8-K
0gbijyaw ty99l2
14 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
kck1orbw
15 Sep 22
Eloxx Pharmaceuticals Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
8:07am
8-K
v5ax368421q
15 Aug 22
Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update
4:18pm
8-K
cx9v1q 2xvux74mjjr9r
15 Jul 22
Changes in Registrant's Certifying Accountant
7:06am
8-K
4zrubz91gp
5 Jul 22
Eloxx Pharmaceuticals Announces Changes to Board of Directors
8:28am
8-K
7ml 1mok9qen
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
b1dkcv
10 May 22
Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
5:28pm
8-K
1fp2zq1hr
4 Apr 22
Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update
8:45am
8-K
vgzytdyg2 jue4gu8och
5 Jan 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
kbgwd
17 Nov 21
Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
7:41am
8-K
8fcj9q
9 Nov 21
Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
8:03am
8-K
rpu6cg
5 Oct 21
Entry into a Material Definitive Agreement
8:10am
8-K
k22c wa1a
30 Sep 21
Entry into a Material Definitive Agreement
8:52am
8-K
fh2 f8zaakos4p08
13 Sep 21
Regulation FD Disclosure
4:07pm